Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam

References

• World Health Organization. Coronavirus (COVID-19) 2021 [ accessed 2022 Jan 1]. https://covid19.who.int
   Google Scholar
• Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccnes. 2021 Jan 2;20(1):23–6. doi:10.1080/14760584.2021.1875824.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant 2021 [ accessed 2022 Jan 21]. https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-b.1.1.529-technical-brief-and-priority-actions-for-member-states
   Google Scholar
• Centers for Disease Control and Prevention. What you need to know about variants [accessed 2022 Apr 26]. https://www.cdc.gov/coronavirus/2019-ncov/variants/about-variants.html
   Google Scholar
• Vasireddy D, Atluri P, Malayala SV, Vanaparthy R, Mohan G. Review of COVID-19 vaccines approved in the United States of America for emergency use. J Clin Med Res. 2021;13(4):204–13. doi:10.14740/jocmr4490. PubMed PMID: 34007358; eng.
   PubMedGoogle Scholar
• Zhang M-X, Zhang T-T, Shi G-F, Cheng F-M, Zheng Y-M, Tung T-H, Chen H-X. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021 Jul 3;20(7):891–98. doi:10.1080/14760584.2021.1925112.
   PubMed Web of Science ®Google Scholar
• Sinopharm. Chinese Covid-19 vaccine efficacy better than expected [accessed 2022 Jan 1]. http://www.sinopharm.com/en/s/1395-4689-38923.html
   Google Scholar
• Centers for Disease Control and Prevention. Selected adverse events reported after COVID-19 vaccination [accessed 2022 Jun 6]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
   Google Scholar
• Ta Park VM, Dougan M, Meyer OL, Nam B, Tzuang M, Park LG, Vuong Q, Tsoh JY. Vaccine willingness: findings from the COVID-19 effects on the mental and physical health of Asian Americans & Pacific Islanders survey study (COMPASS). Preven Med Rep. 2021 Sep 1;23:101480. doi:10.1016/j.pmedr.2021.101480.
   PubMedGoogle Scholar
• Strehle EM, Shabde N. One hundred years of telemedicine: does this new technology have a place in paediatrics? Arch Dis Child. 2006;91(12):956–59. doi:10.1136/adc.2006.099622. PubMed PMID: 17119071; eng.
   PubMed Web of Science ®Google Scholar
• https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html?fbclid=IwAR0_Bf2Au0swgTIytLmBcvv79vFeylwb8Ge-q7SwwrMKlhBK_lPvvAsRuNc
   Google Scholar
• Public Health Scotland. COVID-19 AstraZeneca vaccine and rare blood clots leaflet [ accessed 2022 Jan 1]. http://www.healthscotland.com/documents/45108.aspx
   Google Scholar
• Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt H-P, Attia S. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German Healthcare Workers. Biology. 2021 Aug 5;10(8):752. 10.3390/biology10080752. PubMed PMID: 34439984; PubMed Central PMCID: PMCPMC8389568. eng.
   PubMedGoogle Scholar
• Akaishi T, Onodera T, Takahashi T, Harigae H, Ishii T. Reports of acute adverse events in mRNA COVID-19 vaccine recipients after the first and second doses in Japan. Sci Rep. 2022 Sep 15;12(1):15510. 10.1038/s41598-022-19936-5. PMID: 36109582; PMCID: PMC9476447.
   PubMed Web of Science ®Google Scholar
• Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021 May 26;9(6):556. 10.3390/vaccines9060556. PubMed PMID: 34073382; PubMed Central PMCID: PMCPMC8229440. eng.
   Web of Science ®Google Scholar
• Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021 Jul 1;21(7):939–49. doi:https://doi.org/10.1016/S1473-3099(21)00224-3.
   PubMed Web of Science ®Google Scholar
• Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326(14):1390–99. doi:10.1001/jama.2021.15072.
   PubMed Web of Science ®Google Scholar
• Kant A, Jansen J, van Balveren L, van Hunsel F. Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine Brands. Drug Saf. 2022;45(4):319–31. doi:https://doi.org/10.1007/s40264-022-01151-w.
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, et al. Safety and immunogenicity of the ChAdOx1 nCov-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 Aug 15;396(10249):467–78. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20. Erratum in: Lancet. 2020 Aug 15;396(10249):466. Erratum in: Lancet. 2020 Dec 12;396(10266):1884. PMID: 32702298; PMCID: PMC7445431.
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect Dis. 2022 Feb;22(2):196–208. Epub 2021 Sep 15. PMID: 34536349; PMCID: PMC8443232. doi:10.1016/S1473-3099(21)00462-X.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021 Feb 4;384(5): 403–16. 10.1056/NEJMoa2035389. Epub 2020 Dec 30. PMID: 33378609; PMCID: PMC7787219.
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Kaiki Y, Sugiyama A, Nagashima S, Kurisu A, Nomura T, Omori K, Akita T, Shigemoto N, Tanaka J, et al. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan. J Infect Chemother. 2022 Apr;28(4):576–81. doi:10.1016/j.jiac.2021.12.034. Epub 2022 Jan 11. PMID: 35058126; PMCID: PMC8747950.
   PubMed Web of Science ®Google Scholar
• Nittner-Marszalska M, Rosiek-Biegus M, Kopeć A, Pawłowicz R, Kosińska M, Łata A, Szenborn L. Pfizer-BioNTech COVID-19 vaccine tolerance in allergic versus non-allergic individuals. Vaccines. 2021;9(6):553. doi:10.3390/vaccines9060553. PubMed PMID: 34070671; eng.
   Web of Science ®Google Scholar
• Elgendy MO, El-Gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side effects and efficacy of COVID-19 vaccines among the Egyptian population. Vaccines. 2022;10(1):109. doi:10.3390/vaccines10010109.
   Web of Science ®Google Scholar
• Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021 Oct 1;111:219–26. doi:10.1016/j.ijid.2021.08.013.
   PubMed Web of Science ®Google Scholar
• Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020 Aug 1;35(8):775–79. doi:10.1007/s10654-020-00671-y.
   PubMed Web of Science ®Google Scholar
• Nagata JM. Rapid scale-up of telehealth during the COVID-19 pandemic and implications for subspecialty care in rural areas. J Rural Health. 2021 Jan 1;37(1):145. doi:10.1111/jrh.12433.
   PubMed Web of Science ®Google Scholar
• Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID-19. J Allergy Clin Immunol Pract. 2020;8(5):1489–91. doi:10.1016/j.jaip.2020.03.008. PubMed PMID: 32220575; eng.
   PubMed Web of Science ®Google Scholar
• Vidal-Alaball J, Acosta-Roja R, Pastor Hernández N, et al. Telemedicine in the face of the COVID-19 pandemic. Atención Primaria. 2020;52(6):418–22. doi: 10.1016/j.aprim.2020.04.003.
   PubMed Web of Science ®Google Scholar
• Pengput A, Schwartz DG Telemedicine in Southeast Asia: a systematic review. Telemed J E Health. 2022 Dec;28(12):1711–33. doi:10.1089/tmj.2021.0516. Epub 2022 Apr 12. PMID: 35417250.
   PubMed Web of Science ®Google Scholar